- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03839420
To Compare Early Rotation of Two Extended Depth of Focus Intraocular Lenses (VENUStoric)
February 7, 2023 updated by: Carl Zeiss Meditec AG
Prospective Randomized Clinical Trial Comparing Early Rotation of Two Extended Depth of Focus Intraocular Lenses
To demonstrate that the Carl Zeiss Meditec (CZM) Extended depth of focus (EDOF) Intraocular lens (IOL) is superior to the competitor EDOF IOL with respect to Rotational Stability.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Estelle Poineau
- Phone Number: 0546523154
- Email: estelle.poineau@zeiss.com
Study Locations
-
-
-
Freiburg, Germany
- Universitätsklinikum Freiburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient informed of the consequences and constraints of the Clinical Investigational Plan and who has given his/her written informed consent
- Patients of any gender, aged 18 or older
- Assured follow-up examinations
- Healthy eyes with clinically significant age related cataract requiring surgical treatment
- Corrected distance visual acuity projected to be better than 0.2 logMAR after the cataract surgery, as determined by Investigator's medical judgment
- Uni- and/or bilaterally regular corneal astigmatism ≥ 1.0 D and ≤ 3.0 D (confirmed by topography measurement)
8. Cataract density compatible with biometry measurement
Exclusion Criteria:
- Patients unable to meet the limitations of the Clinical Investigational Plan or likely of non-cooperation during the trial
- Patients whose freedom is impaired by administrative or legal order
- Current participation in another drug or device investigation that affects patients vision
- Ocular disorders, other than cataract, that could potentially cause future acuity loss
- Have atonic pupil or physiologically small pupil (unable to dilate to at least 5 mm)
- Any anterior segment pathology that could significantly affect outcomes (e.g. chronic or recurrent uveitis, iritis, aniridia, rubeosis iridis, etc.)
- Abnormal corneal findings in either eye (e.g. keratoconus, pellucid marginal degeneration, or irregular astigmatism, clinically significant corneal membrane dystrophies)
- Any condition in the study eye that could affect IOL stability (e.g. zonular dialysis, evident zonular weakness or dehiscence, Floppy iris syndrome etc.)
- History of any clinically significant retinal pathology or ocular diagnosis (e.g. diabetic retinopathy, ischemic diseases, macular degeneration, retinal detachment, optic neuropathy optic nerve atrophy, amblyopia, strabismus, microphthalmus, epiretinal membrane, Choroidal hemorrhage etc.) in the study eyes that could alter or limit final postoperative visual prognosis
- Pseudoexfoliation syndrome (according to investigator decision)
- Pathologic miosis or Pharmacotherapy with miotic agent
- Irregular astigmatism / Keratoconus
- Uncontrolled glaucoma or IOP higher than 24mmHg under ocular hypertension treatment.
- All kind of infections (acute ocular disease, external / internal infection, systemic infection)
- Traumatic cataract
- Monophthalmic patient
- Patients, who are unable to fixate for a longer time, e.g. strabismus, nystagmus
- Patient expected to require retinal laser treatment before the end of the last follow-up examination
- Patient expected to require refractive laser treatment / refractive laser touch-up before the end of the last follow-up examination
- Previous intraocular and corneal / refractive surgery
- Current Systemic or ocular pharmacotherapy that effects patients vision (according to investigator decision)
- Dementia
- Previous use of cytotoxic drugs or total body irradiation within last 2 years
- Any other pathology or condition presenting, according to the investigator opinion, a risk for the patient
- Pregnancy and / or lactation period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: CZM IOL
|
implantation of CZM IOL
|
ACTIVE_COMPARATOR: Competitor IOL
|
implantation of Competitor IOL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IOL axis
Time Frame: Immediately after the surgery
|
IOL axis will be analyzed based on images.
|
Immediately after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 8, 2019
Primary Completion (ACTUAL)
October 4, 2020
Study Completion (ACTUAL)
February 17, 2021
Study Registration Dates
First Submitted
February 1, 2019
First Submitted That Met QC Criteria
February 12, 2019
First Posted (ACTUAL)
February 15, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2023
Last Update Submitted That Met QC Criteria
February 7, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 929MP BER-401-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
National University Hospital, SingaporeSingapore General HospitalCompletedCataract Surgery | Stress Levels | Music Improving Outcomes in Cataract SurgerySingapore
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
Clinical Trials on CZM IOL
-
Peking University Third HospitalPeople's Hospital of GuangxiRecruitingPresbyopia | Cataract SenileChina
-
University of TriesteCompleted
-
Peking University Third HospitalUnknown
-
Maastricht University Medical CenterAbbott Medical OpticsCompletedCataract | PresbyopiaNetherlands
-
Enrique Ordiñaga-Monreal, OD, MScUnknownAstigmatism | Visual Acuity | IOL | Cataract AfterSpain
-
Iladevi Cataract and IOL Research CenterCompletedCongenital CataractIndia
-
Cutting Edge SASNot yet recruiting
-
Carolina Eyecare Physicians, LLCScience in VisionRecruiting
-
Bausch & Lomb IncorporatedCompleted
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityUnknown